SEC Form SC 13G/A filed by DarioHealth Corp. (Amendment)

2/13/23 9:30:28 AM ET

$DRIO

Medical/Dental Instruments

Health Care

Get the next $DRIO alert in real time by email

SC 13G/A 1 zk2329192.htm SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

(Amendment No. 1)*

DarioHealth Corp.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

23725P209

(CUSIP Number)

December 31, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 23725P209

13G

Page 2 of 17 Pages

1	NAME OF REPORTING PERSONS Y.D More Investments Ltd.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) CO

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) on December 30, 2022.

CUSIP No. 23725P209

13G

Page 3 of 17 Pages

1	NAME OF REPORTING PERSONS More Provident Funds and Pension Ltd.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,288,517.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,288,517.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,288,517.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.02% () (*)
12	TYPE OF REPORTING PERSON (See instructions) CO

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

CUSIP No. 23725P209

13G

Page 4 of 17 Pages

1	NAME OF REPORTING PERSONS B.Y.M. Mor Investments Ltd.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) CO

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

CUSIP No. 23725P209

13G

Page 5 of 17 Pages

1	NAME OF REPORTING PERSONS Eli Levy
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) IN

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

CUSIP No. 23725P209

13G

Page 6 of 17 Pages

1	NAME OF REPORTING PERSONS Yosef Levy
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) IN

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

CUSIP No. 23725P209

13G

Page 7 of 17 Pages

1	NAME OF REPORTING PERSONS Benjamin Meirov
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel and U.S.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) IN

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

CUSIP No. 23725P209

13G

Page 8 of 17 Pages

1	NAME OF REPORTING PERSONS Yosef Meirov
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel and Belgium

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) IN

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

CUSIP No. 23725P209

13G

Page 9 of 17 Pages

1	NAME OF REPORTING PERSONS Michael Meirov
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel and U.S.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) IN

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

CUSIP No. 23725P209

13G

Page 10 of 17 Pages

1	NAME OF REPORTING PERSONS Dotan Meirov
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Israel and U.S.

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER ---
	6	SHARED VOTING POWER 1,518,025.61 (*)
	7	SOLE DISPOSITIVE POWER ---
	8	SHARED DISPOSITIVE POWER 1,518,025.61 (*)

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,518,025.61 (*)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.91% () (*)
12	TYPE OF REPORTING PERSON (See instructions) IN

(*) The beneficial ownership of the securities reported herein is described in Item 4(a).

(**) Based on 25,679,410 shares of Common Stock outstanding as of December 28, 2022, as provided in the Issuer’s Registration Statement on Form S-3 filed with the SEC on December 30, 2022.

Item 1. (a)

Name of Issuer:

DarioHealth Corp.

(b)	Address of Issuer's Principal Executive Offices:

18 W. 18^th St., New York, NY

Item 2. (a)

Name of Person Filing:

Y.D More Investments Ltd.

More Provident Funds and Pension Ltd.

B.Y.M. Mor Investments Ltd.

Eli Levy

Yosef Levy

Benjamin Meirov

Yosef Meirov

Michael Meirov

Dotan Meirov

(b)

Address of Principal Business Office:

Y.D More Investments Ltd. – 2 Ben-Gurion Street, Ramat Gan, Israel

More Provident Funds and Pension Ltd. – 2 Ben-Gurion Street, Ramat Gan, Israel

B.Y.M. Mor Investments Ltd. – 23 Tuval St., Ramat Gan, Israel

Eli Levy – 2 Ben-Gurion Street, Ramat Gan, Israel

Yosef Levy – 2 Ben-Gurion Street, Ramat Gan, Israel

Benjamin Meirov – 32 Bazel St., Herzliya, Israel

Yosef Meirov – 18 Shevet Menashe St., Herzliya, Israel

Michael Meirov – 32 Ben Tzvi St., Herzliya, Israel

Dotan Meirov – 38 Nili St., Herzliya, Israel

(c)

Citizenship:

Y.D More Investments Ltd. - Israel

More Provident Funds and Pension Ltd. - Israel

B.Y.M. Mor Investments Ltd. - Israel

Eli Levy – Israel

Yosef Levy – Israel

Benjamin Meirov – Israel and U.S.

Yosef Meirov – Israel and Belgium

Michael Meirov – Israel and U.S.

Dotan Meirov – Israel and U.S.

(d)

Title of Class of Securities:

Common Stock, par value $0.0001 per share

(e)

CUSIP Number:

23725P209

Item 3.

Not applicable.

Item 4.

Ownership:

(a)

Amount beneficially owned:

See row 9 of cover page of each reporting person.

The securities reported herein are held either by More Provident Funds and Pension Ltd. for the benefit of beneficiaries of various provident and pension funds or by More Investment House Portfolio Management Ltd. for the benefit of various portfolio management clients.

More Provident Funds and Pension Ltd. and More Investment House Portfolio Management Ltd. are controlled by Y.D More Investments Ltd., which is controlled by (a) Yosef Meirov, directly and through B.Y.M. Mor Investments Ltd., a company which he controls with Michael Meirov and Dotan Meirov, (b) Eli Levy through Elldot Ltd., a wholly owned company, (c) Yosef Levy and (d) Benjamin Meirov.

This Statement shall not be construed as an admission by any of the Reporting Persons that it or he is the beneficial owner of any of the securities covered by this Statement, and each Reporting Person disclaims beneficial ownership of any such securities.

(b)

Percent of class:

See row 11 of cover page of each reporting person

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote:

See row 5 of cover page of each reporting person

(ii)

Shared power to vote or to direct the vote:

See row 6 of cover page of each reporting person and note in Item 4(a) above

(iii)

Sole power to dispose or to direct the disposition of:

See row 7 of cover page of each reporting person

(iv)

Shared power to dispose or to direct the disposition of:

See row 8 of cover page of each reporting person and note in Item 4(a) above

Item 5.

Ownership of Five Percent or Less of a Class:

Not applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another:

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not applicable.

Item 8.

Identification and Classification of Members of the Group:

Not applicable.

Item 9.

Notice of Dissolution of Group:

Not applicable.

Item 10.

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 13, 2023

	Y.D More Investments Ltd. /s/ Yosef Levy By: Yosef Levy* Title: Co-CEO

	/s/ Meir Gridish By: Meir Gridish* Title: Chairman of the Board

	More Provident Funds and Pension Ltd. /s/ Yosef Levy By: Yosef Levy* Title: Director

	/s/ Meir Gridish By: Meir Gridish* Title: Chairman of the Board

* Signature duly authorized by resolution of the Board of Directors and filed herewith.

	B.Y.M. Mor Investments Ltd. /s/ Meir Gridish By: Meir Gridish Title: Director and CEO

	/s/ Eli Levy Eli Levy

	/s/ Yosef Levy Yosef Levy

	** Name: Benjamin Meirov

** The undersigned, by signing his name hereto, executes this Schedule 13G/A pursuant to the Limited Power of Attorney executed on behalf of Mr. Benjamin Meirov and filed herewith.

	/s/ Meir Gridish Name: Meir Gridish Attorney-in-Fact

	*** Name: Yosef Meirov

*** The undersigned, by signing his name hereto, executes this Schedule 13G/A pursuant to the Limited Power of Attorney executed on behalf of Mr. Yosef Meirov and filed herewith.

	/s/ Meir Gridish Name: Meir Gridish Attorney-in-Fact

	**** Name: Michael Meirov

**** The undersigned, by signing his name hereto, executes this Schedule 13G/A pursuant to the Limited Power of Attorney executed on behalf of Mr. Michael Meirov and filed herewith.

	/s/ Meir Gridish Name: Meir Gridish Attorney-in-Fact

	***** Name: Dotan Meirov

***** The undersigned, by signing his name hereto, executes this Schedule 13G/A pursuant to the Limited Power of Attorney executed on behalf of Mr. Dotan Meirov and filed herewith.

	/s/ Meir Gridish Name: Meir Gridish Attorney-in-Fact

EXHIBIT NO.

DESCRIPTION

Exhibit 1

Joint Filing Agreement by and among the Reporting Persons (incorporated herein by reference to Exhibit 1 to Schedule 13G filed by the Reporting Persons on July 25, 2022 to report beneficial ownership of shares of the Issuer).

Exhibit 2

Resolution of Board of Directors regarding signature authority of Y.D More Investments Ltd. (incorporated herein by reference to Exhibit 2 to Schedule 13G filed by the Reporting Persons on June 21, 2022 to report beneficial ownership of shares of Brenmiller Energy Ltd.)

Exhibit 3

Resolution of Board of Directors regarding signature authority of More Provident Funds and Pension Ltd (incorporated herein by reference to Exhibit 3 to Schedule 13G filed by the Reporting Persons on June 21, 2022 to report beneficial ownership of shares of Brenmiller Energy Ltd.)

Exhibit 4

Limited Power of Attorney executed on behalf of Mr. Benjamin Meirov (incorporated herein by reference to Exhibit 4 to Schedule 13G filed by the Reporting Persons on June 21, 2022 to report beneficial ownership of shares of Brenmiller Energy Ltd.)

Exhibit 5

Limited Power of Attorney executed on behalf of Mr. Yosef Meirov (incorporated herein by reference to Exhibit 5 to Schedule 13G filed by the Reporting Persons on June 21, 2022 to report beneficial ownership of shares of Brenmiller Energy Ltd.)

Exhibit 6

Limited Power of Attorney executed on behalf of Mr. Michael Meirov (incorporated herein by reference to Exhibit 6 to Schedule 13G filed by the Reporting Persons on June 21, 2022 to report beneficial ownership of shares of Brenmiller Energy Ltd.)

Exhibit 7

Limited Power of Attorney executed on behalf of Mr. Dotan Meirov (incorporated herein by reference to Exhibit 7 to Schedule 13G filed by the Reporting Persons on June 21, 2022 to report beneficial ownership of shares of Brenmiller Energy Ltd.)

Get the next $DRIO alert in real time by email

Date	Price Target	Rating	Analyst
1/29/2025	$2.00 → $1.00	Buy → Hold	TD Cowen
5/13/2022	$8.75	Neutral → Buy	Alliance Global Partners
1/26/2022	$28.00 → $25.00	Buy	Aegis Capital
8/19/2021	$35.00 → $28.00	Buy	Aegis Capital

SEC Form SC 13G/A filed by DarioHealth Corp. (Amendment)

Chat with this insight

Recent Analyst Ratings for $DRIO

$DRIO SEC Filings

DarioHealth Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

DarioHealth Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

DarioHealth Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

$DRIO Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Commercial Officer Nelson Steven Charles bought $4,546 worth of shares (5,000 units at $0.91), increasing direct ownership by 10% to 55,000 units (SEC Form 4)

Chief Commercial Officer Nelson Steven Charles bought $8,244 worth of shares (10,000 units at $0.82), increasing direct ownership by 25% to 50,000 units (SEC Form 4)

Chief Commercial Officer Nelson Steven Charles bought $12,292 worth of shares (15,000 units at $0.82), increasing direct ownership by 60% to 40,000 units (SEC Form 4)

$DRIO Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

DarioHealth downgraded by TD Cowen with a new price target

DarioHealth upgraded by Alliance Global Partners with a new price target

Aegis Capital reiterated coverage on DarioHealth with a new price target

$DRIO Press Releases

Fastest customizable press release news feed in the world

DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025

DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives

DarioHealth Announces CFO Transition

$DRIO Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by DarioHealth Corp.

SEC Form SC 13G filed by DarioHealth Corp.

SEC Form SC 13G/A filed by DarioHealth Corp. (Amendment)

$DRIO Financials

Live finance-specific insights

DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025

DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results

DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025

$DRIO Leadership Updates

Live Leadership Updates

DarioHealth Appoints Healthcare Industry Leader Larry Leisure to Board of Directors

OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors

Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer

$DRIO Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

New insider Leisure Lawrence B. claimed ownership of 258,000 shares (SEC Form 3)

Director Kaplan Jon H. was granted 30,000 shares, increasing direct ownership by 37% to 111,574 units (SEC Form 4)

SEC Form 4 filed by Director Stern Adam K

Recent Analyst Ratings for
$DRIO

$DRIO
SEC Filings

$DRIO
Insider Purchases

$DRIO
Analyst Ratings

$DRIO
Press Releases

$DRIO
Large Ownership Changes

$DRIO
Financials

$DRIO
Leadership Updates

$DRIO
Insider Trading